In addition to the recordkeeping requirements for dispensers and researchers provided in § 1304.22 , practitioners dispensing gamma-hydroxybutyric acid that is manufactured or distributed in accordance with an application under section 505 of the Federal Food, Drug, and Cosmetic Act must maintain and make available for inspection and copying by the Attorney General, all of the following information for each prescription:
21 C.F.R. §1304.26